Jane Street
ANIP icon

Jane Street’s ANI Pharmaceuticals ANIP Stock Holding History

Jane Street’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,657
Closed -$2M – 11486
2025
Q4 		$2.03M Sell
25,657
-108,782
-81% -$9.42M ﹤0.01% 4782
2025
Q3 		$12.3M Buy
+134,439
New +$11M ﹤0.01% 2161
2025
Q2 		– Sell
-40,423
Closed -$2.71M – 9543
2025
Q1 		$2.71M Buy
+40,423
New +$2.41M ﹤0.01% 3875
2024
Q4 		– Sell
-19,976
Closed -$1.19M – 9324
2024
Q3 		$1.19M Sell
19,976
-6,287
-24% -$384K ﹤0.01% 5539
2024
Q2 		$1.67M Sell
26,263
-41,090
-61% -$2.67M ﹤0.01% 4807
2024
Q1 		$4.66M Buy
67,353
+53,136
+374% +$3.21M ﹤0.01% 2716
2023
Q4 		$784K Sell
14,217
-6,571
-32% -$362K ﹤0.01% 6012
2023
Q3 		$1.21M Buy
+20,788
New +$1.2M ﹤0.01% 4904
2023
Q2 		– Sell
-11,820
Closed -$524K – 8622
2023
Q1 		$469K Sell
11,820
-14,627
-55% -$617K ﹤0.01% 6429
2022
Q4 		$1.06M Buy
+26,447
New +$993K ﹤0.01% 4902
2022
Q1 		– Sell
-9,414
Closed -$434K – 10218
2021
Q4 		$434K Buy
+9,414
New +$405K ﹤0.01% 7514
2021
Q1 		– Sell
-14,067
Closed -$409K – 9044
2020
Q4 		$409K Buy
+14,067
New +$403K ﹤0.01% 6009
2018
Q1 		– Sell
-6,382
Closed -$411K – 4754
2017
Q4 		$411K Buy
+6,382
New +$397K ﹤0.01% 3402
2016
Q2 		– Sell
-8,395
Closed -$283K – 4024
2016
Q1 		$283K Buy
+8,395
New +$285K ﹤0.01% 3280
2015
Q2 		– Sell
-13,539
Closed -$847K – 3597
2015
Q1 		$847K Buy
+13,539
New +$824K 0.01% 1519
2014
Q4 		– Sell
-14,096
Closed -$399K – 2445
2014
Q3 		$399K Sell
14,096
-20,541
-59% -$616K ﹤0.01% 1637
2014
Q2 		$1.19M Buy
34,637
+21,402
+162% +$671K 0.02% 805
2014
Q1 		$415K Buy
+13,235
New +$351K ﹤0.01% 1732

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Jane Street's ANIP Position: Q1 2026 in Review

Jane Street sold out of ANI Pharmaceuticals (ANIP) in Q1 2026, closing a stake of 25,657 shares — an estimated $2M sold.

Jane Street first reported a position in ANIP in Q1 2014 and held it in 18 quarters. The position peaked at $12.3M in Q3 2025. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Jane Street reported no remaining ANI Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 25,657 ANI Pharmaceuticals shares in Q1 2026, an estimated $2M.
  • Jane Street first reported a position in ANI Pharmaceuticals in Q1 2014 and held it in 18 quarters.
  • Jane Street's ANI Pharmaceuticals position peaked at $12.3M in Q3 2025.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.